Found 87 results
[ Author(Desc)] Title Type Year
Filters: Author is Bermudez, Luiz E  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
L. E. Bermudez, Kolonoski, P., Wu, M., Aralar, P. A., Inderlied, C. B., and Young, L. S., Mefloquine is active in vitro and in vivo against Mycobacterium avium complex., Antimicrobial agents and chemotherapy, vol. 43, no. 8, pp. 1870-4, 1999.
L. E. Bermudez and Champsi, J., Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice., Infection and immunity, vol. 61, no. 7, pp. 3093-7, 1993.
L. E. Bermudez and Inderlied, C. B., Effect of Mycobacterium avium infection on the influx, accumulation, and efflux of KRM-1648 by human macrophages., Microbial drug resistance (Larchmont, N.Y.), vol. 3, no. 3, pp. 277-82, 1997.
L. E. Bermudez, Young, L. S., and Enkel, H., Interaction of Mycobacterium avium complex with human macrophages: roles of membrane receptors and serum proteins., Infection and immunity, vol. 59, no. 5, pp. 1697-702, 1991.
L. E. Bermudez and Kaplan, G., Recombinant cytokines for controlling mycobacterial infections., Trends in microbiology, vol. 3, no. 1, pp. 22-7, 1995.
L. E. Bermudez and Young, L. S., Killing of Mycobacterium avium: insights provided by the use of recombinant cytokines., Research in microbiology, vol. 141, no. 2, pp. 241-3, 1990.
L. E. Bermudez and Yamazaki, Y., Effects of macrolides and ketolides on mycobacterial infections., Current pharmaceutical design, vol. 10, no. 26, pp. 3221-8, 2004.
L. E. Bermudez, Kemper, C. A., and Deresinski, S. C., Dysfunctional monocytes from a patient with disseminated Mycobacterium kansasii infection are activated in vitro and in vivo by GM-CSF., Biotherapy (Dordrecht, Netherlands), vol. 8, no. 2, pp. 135-42, 1994.
L. E. Bermudez, [Use of monoclonal antibodies in the diagnosis and treatment of infection in immunocompromised patients]., Revista paulista de medicina, vol. 105, no. 6, pp. 341-6, 1987.
L. E. Bermudez, Wagner, D., and Sosnowska, D., Mechanisms of Mycobacterium avium pathogenesis., Archivum immunologiae et therapiae experimentalis, vol. 48, no. 6, pp. 521-7, 2000.
L. E. Bermudez, Petrofsky, M., and Stevens, P., Treatment with recombinant granulocyte colony-stimulating factor (Filgrastin) stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice., Immunology, vol. 94, no. 3, pp. 297-303, 1998.
L. E. Bermudez, Wu, M., Young, L. S., and Inderlied, C. B., Postantibiotic effect of amikacin and rifapentine against Mycobacterium avium complex., The Journal of infectious diseases, vol. 166, no. 4, pp. 923-6, 1992.